Literature DB >> 9013981

Lipopolysaccharide-induced biphasic inositol 1,4,5-trisphosphate response and tyrosine phosphorylation of 140-kilodalton protein in mouse peritoneal macrophages.

H Shinji1, K S Akagawa, M Tsuji, M Maeda, R Yamada, K Matsuura, S Yamamoto, T Yoshida.   

Abstract

We previously showed that a relatively high dose of LPS induced the selective translocation of protein kinase C-beta (PKC-beta) in LPS-responsive mouse macrophages. This result suggested that phosphatidylinositol-specific phospholipase C (PLC) might be activated in the upstream of PKC-beta. Stimulation of C3H/HeN mouse macrophages by LPS induced the characteristic phosphatidylinositol-1,4,5-trisphosphate (IP3) response, that is, a biphasic response consisting of a rapid increase occurring within the first 1 min, and another increase beginning at around 1 min after stimulation. Only the first response was disappeared when cells were treated with a platelet-activating factor receptor antagonist. LPS-inducible TNF-alpha gene activation, however, was not suppressed by the same antagonist, but suppressed by PKC inhibitors. LPS-stimulated macrophage lysates showed tyrosine phosphorylation of some proteins, and the strongest phosphorylation was observed at molecular mass of 140 kDa. The phosphorylation of this protein started at 40 s after LPS stimulation and continued to increase. Anti-PLC-gamma2 Ab seemed to recognize the same protein as the tyrosine-phosphorylated 140-kDa protein. A low dose of LPS (1 ng/ml) could not induce the tyrosine phosphorylation of this protein. Furthermore, LPS induced only the first phase change, but not the second phase increase in LPS-hyporesponsive C3H/HeJ mouse macrophages. These results indicate that the first phase rapid IP3 change, which is also seen in HeJ macrophages, is mediated via a platelet-activating factor receptor, and is not responsible for TNF-alpha production, while the second phase change mediated by a molecule other than CD14 is responsible for PKC-beta translocation and TNF-alpha production. The results also suggest that the later IP3 change is considered to be mediated through a gamma2 type of phosphatidylinositol-specific PLC.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9013981

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization.

Authors:  Tadayuki Iwase; Yoshio Uehara; Hitomi Shinji; Akiko Tajima; Hiromi Seo; Koji Takada; Toshihiko Agata; Yoshimitsu Mizunoe
Journal:  Nature       Date:  2010-05-20       Impact factor: 49.962

2.  Pasteurella haemolytica A1-derived leukotoxin and endotoxin induce intracellular calcium elevation in bovine alveolar macrophages by different signaling pathways.

Authors:  S L Hsuan; M S Kannan; S Jeyaseelan; Y S Prakash; G C Sieck; S K Maheswaran
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

3.  Calcium/calmodulin-dependent protein kinase II regulates cyclooxygenase-2 expression and prostaglandin E2 production by activating cAMP-response element-binding protein in rat peritoneal macrophages.

Authors:  Xueyuan Zhou; Junying Li; Wenxiu Yang
Journal:  Immunology       Date:  2014-10       Impact factor: 7.397

4.  Lipopolysaccharide induction of MARCKS-related protein and cytokine secretion are differentially impaired in microglia from LPS-nonresponsive (C3H/HeJ) mice.

Authors:  D M Byers; S D Rosé; H W Cook; C Hao; S Fedoroff
Journal:  Neurochem Res       Date:  1998-12       Impact factor: 3.996

5.  Inhibition of store-operated calcium entry in microglia by helminth factors: implications for immune suppression in neurocysticercosis.

Authors:  Yuyang Sun; Arun Chauhan; Pramod Sukumaran; Jyotika Sharma; Brij B Singh; Bibhuti B Mishra
Journal:  J Neuroinflammation       Date:  2014-12-24       Impact factor: 8.322

6.  Lipopolysaccharide induces endoplasmic store Ca2+-dependent inflammatory responses in lung microvessels.

Authors:  Kathirvel Kandasamy; Lavanya Bezavada; Rachel B Escue; Kaushik Parthasarathi
Journal:  PLoS One       Date:  2013-05-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.